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Variables
Univariate analysis Multivariate analysis
Odd ratio 95% CI P-value Odd ratio 95% CI P-value
Age 0.998 0.966w1.031 0.905
Male gender 0.816 0.377w1.764 0.605
Hypertension 3.141 0.935w10.549 0.064
Diabetes 2.211 1.075w4.546 0.031
Current smoker 1.309 0.665w2.578 0.436
Old myocardial infarction 1.385 0.703w2.728 0.347
Heart failure 1.971 0.953w4.075 0.067
ESRD on maintenance hemodialysis 2.523 1.242w5.126 0.010 2.194 1.062w4.531 0.034
Ostial lesion 2.664 1.338w5.303 0.005 2.374 1.176w4.792 0.016
Left main bifurcation 2.336 1.104w4943 0.027
Previous stent as Drug eluting stent 1.673 0.845w3.312 0.140
Pre-PCI stenosis 1.027 1.000w.054 0.053
IVUS use 0.621 0.283w1.362 0.234
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ostial lesion were independent predictors of repeat in-stent restenosis
after DEB use.
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BACKGROUND The purpose of this study is to assess the vascular
response of de novo coronary lesions treated with paclitaxel-coated
balloon (PCB) using intravascular ultrasound virtual histology (IVUS-
VH) and fractional ﬂow reserve (FFR).
METHODS This prospective observational study enrolled 27 patients
with coronary artery disease treated with PCB who underwent coro-
nary angiography, IVUS-VH and FFR before, immediately after inter-
vention and at 9 months. 28 de novo lesions were successfully treated
with PCB.
RESULTS Angiographic late luminal loss was 0.02  0.27mm. Mean
vessel and lumen areas showed increase at 9 months (12.0  3.5mm2
to 13.2  3.9mm2, p <0.001; and 5.4  1.2mm2 to 6.5  1.8mm2,
p <0.001, respectively). Although mean plaque area was unchanged
(6.6  2.6mm2 to 6.6  2.4mm2, p ¼ 0.269), plaque burden decreased
signiﬁcantly (53.4  7.9% to 49.5  6.4%, p ¼ 0.002). The proportion
of all four plaque compositions by IVUS-VH was unchanged at 9
months. The FFR of the treated lesion was 0.71  0.13 pre-procedure,
0.87  0.06 post-procedure and 0.84  0.06 at follow-up.CONCLUSIONS De novo coronary lesions treated with PCB showed
persistent anatomical and physiological patency with plaque redis-
tribution and vessel remodeling without chronic elastic recoil or pla-
que compositional change during follow-up.
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